Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Kalayci M, Cetinkaya E, Erol MK. Prevalence of primary open-angle glaucoma in a Somalia population. Int Ophthalmol 2020;41:581-586. [PMID: 33057866 DOI: 10.1007/s10792-020-01612-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Accepted: 10/02/2020] [Indexed: 10/23/2022]

For:	Kalayci M, Cetinkaya E, Erol MK. Prevalence of primary open-angle glaucoma in a Somalia population. Int Ophthalmol 2020;41:581-586. [PMID: 33057866 DOI: 10.1007/s10792-020-01612-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Accepted: 10/02/2020] [Indexed: 10/23/2022]

Number

Cited by Other Article(s)

Prevalence and Risk Factors of Glaucoma Among Chinese People.From the China Health and Retirement Longitudinal Study. J Glaucoma 2022;31:789-795. [PMID: 35980856 DOI: 10.1097/ijg.0000000000002094] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2022] [Accepted: 07/14/2022] [Indexed: 11/25/2022]

Abstract

PRCIS

This study demonstrated the prevalence of self-reported glaucoma and its strong association with pre-existing systemic chronic diseases in China using the baseline data from CHARLS, a nationwide population-based cohort.

PURPOSE

To estimate the prevalence of self-reported glaucoma and its risk factors using data from the China Health and Retirement Longitudinal Study (CHARLS).

MATERIALS AND METHODS

Data on age, sex, area of residence, education, marital status, health-related behaviors, and pre-existing comorbidities for this cross-sectional study were retrieved from the CHARLS for 17,713 subjects who completed a questionnaire between June 2011 and March 2012. The prevalence of glaucoma was estimated, and a multivariate weighted analysis was performed to estimate the odds ratios (ORs) of its risk factors.

RESULTS

Of 16,599 respondents (93.7%) who answered questions regarding glaucoma and their history of systemic chronic diseases, 314 (1.89%) reported having glaucoma before the index date. Qinghai and Beijing had the highest prevalence of glaucoma in China. Glaucoma was significantly associated with hypertension (OR 1.362 [95% confidence interval (CI) 1.801-2.470]), diabetes (OR 2.597 [95% CI 1.661-10.207]), dyslipidemia (OR 1.757 [95% CI 1.157-3.650]), lung disease (OR 2.098 [95% CI 1.674-6.527]), stroke (OR 5.278 [95% CI 1.094-25.462]), heart disease (OR 1.893 [95% CI 1.237-3.363]), and health-related behaviors such as smoking and alcohol consumption after adjusting for age, sex, area, education, marital status, and medical insurance.

CONCLUSIONS

Geographic variation in the prevalence of self-reported glaucoma and its strong association with pre-existing systemic chronic diseases were observed, suggesting that in addition to ophthalmological examinations, regular physical examinations are necessary for glaucoma patients, especially in areas of high incidence. Appropriate strategies to improve preventive measures for glaucoma are recommended for the Chinese population.

Collapse

Maddala R, Ho LTY, Karnam S, Navarro I, Osterwald A, Stinnett SS, Ullmer C, Vann RR, Challa P, Rao PV. Elevated Levels of Growth/Differentiation Factor-15 in the Aqueous Humor and Serum of Glaucoma Patients. J Clin Med 2022;11:jcm11030744. [PMID: 35160195 PMCID: PMC8837086 DOI: 10.3390/jcm11030744] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2022] [Revised: 01/23/2022] [Accepted: 01/26/2022] [Indexed: 01/11/2023] Open

Affiliation(s)

Rupalatha Maddala Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Leona T. Y. Ho Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Shruthi Karnam Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Iris Navarro Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Anja Osterwald Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland; (A.O.); (C.U.)
Sandra S. Stinnett Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Christoph Ullmer Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland; (A.O.); (C.U.)
Robin R. Vann Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.)
Pratap Challa Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.) Duke Eye Center, Duke University, Durham, NC 27710, USA Correspondence: (P.C.); (P.V.R.); Tel.: +919-684-3282 (P.C.); +919-681-5883 (P.V.R.); Fax: +919-681-8267 (P.C.); +919-684-8983 (P.V.R.)
Ponugoti V. Rao Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA; (R.M.); (L.T.Y.H.); (S.K.); (I.N.); (S.S.S.); (R.R.V.) Duke Eye Center, Duke University, Durham, NC 27710, USA Correspondence: (P.C.); (P.V.R.); Tel.: +919-684-3282 (P.C.); +919-681-5883 (P.V.R.); Fax: +919-681-8267 (P.C.); +919-684-8983 (P.V.R.)

Collapse